In PLOS Genetics, members of the Accelerating Medicines Partnership for Alzheimer's Disease (AMP-AD) consortium outline findings from a brain transcriptome-based search for neurological and psychiatric disease drug targets.
In PLOS Genetics, members of the Accelerating Medicines Partnership for Alzheimer's Disease (AMP-AD) consortium outline findings from a brain transcriptome-based search for neurological and psychiatric disease drug targets.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.